The healthcare industry has been a top priority of U.S. antitrust enforcers in the past decade, with a high proportion of healthcare mergers and business practices subject to investigation and challenge by antitrust officials at the FTC and DOJ. The focus on healthcare is perhaps not surprising: healthcare costs are high and rising, and President Obama made healthcare reform a top priority of his administration. Republican administrations historically have taken a less interventionist approach to antitrust enforcement, raising speculation about whether the new administration will lessen antitrust scrutiny of the healthcare industry.
Join Maria Raptis, a partner in the Antitrust and Competition Group of Skadden, Arps, Slate, Meagher & Flom, LLP, as she reviews recent antitrust enforcement activity in healthcare, explains why antitrust scrutiny of the healthcare industry will
I was engaged with the presenter in this material. She did a great job.
Instructor was knowledgeable; organized and had a style that I could follow. Very focused too!
very informative and good presentation overall